Le Lézard
Classified in: Health, Science and technology, Business
Subjects: EARNINGS, Conference Call, Webcast, Advisory

Schrödinger to Announce First Quarter 2024 Financial Results on May 1


Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its first quarter 2024 financial results on Wednesday, May 1, 2024, after the financial markets close. The company will host a conference call and webcast at 4:30 p.m. ET.

The live webcast can be accessed in the "Investors" section of Schrödinger's website and will be archived for approximately 90 days following the event.

About Schrödinger

Schrödinger is transforming the way therapeutics and materials are discovered. Schrödinger has pioneered a physics-based computational platform that enables discovery of high-quality, novel molecules for drug development and materials applications more rapidly and at lower cost compared to traditional methods. The software platform is licensed by biopharmaceutical and industrial companies, academic institutions, and government laboratories around the world. Schrödinger's multidisciplinary drug discovery team also leverages the software platform to advance a portfolio of collaborative and proprietary programs to address unmet medical needs.

Founded in 1990, Schrödinger has approximately 850 employees and is engaged with customers and collaborators in more than 70 countries. To learn more, visit www.schrodinger.com, follow us on LinkedIn and Instagram, or visit our blog, Extrapolations.com.


These press releases may also interest you

at 21:00
LG Electronics' (LG) CEO, William Cho, has embarked on a strategic business trip to the tech-rich western United States, a hotspot for global tech titans and dynamic AI dialogues. Throughout his week-long visit, Cho will focus on key tasks such as...

at 20:25
Zai Lab Limited today announced that the National Medical Products Administration (NMPA) in China has approved the New Drug Application (NDA) for AUGTYROtm (repotrectinib) for the treatment of adult patients with locally advanced or metastatic...

at 20:05
PBC Biomed is proud to unveil its latest venture, PBC BioVet, a dedicated affiliate aimed at revolutionizing veterinary healthcare. With a steadfast commitment to enhancing animal patient wellbeing and accelerating healing, PBC BioVet is poised to...

at 18:05
Druva, the first and only at-scale SaaS platform for data security, today announced that its strategic partnership with NEXTGEN Group, a prominent IT distribution and services company, has been extended to include Malaysia and Singapore. This...

at 11:30
Jupiter Ed, a leading Student Information and Learning Management System, has recently achieved the Ed-Fi Alliance Student...

at 10:42
Pudgy Penguins, the IP and brand development company behind the series of globally recognized characters, today...



News published on and distributed by: